EltoumM.A., WrightS., AtchleyJ., MasonJ.C.Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen.Perit Dial Int2006; 26: 203–6.
4.
AllariaP.M., GiangrandeA., GandiniE., PisoniI.B.Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?J Nephrol1999; 12: 395–7.
5.
TurnerM.W., HollemanJ.H., CharlotteN.C.Successful therapy of sclerosing peritonitis.Semin Dial1992; 5: 316.
6.
PollockC.A.Bloody ascites in patient after transfer from peritoneal dialysis to hemodialysis.Semin Dial2003; 16: 406–10.
7.
EvrenkayaT.R., AtasoyuE.M., UnverS., BasekimC., BalogluH., TulbekM.Y.Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant2004; 19: 2423–4.
8.
del PesoG., BajoA.M., GilF., AguileraA., RosS., CosteroO.Clinical experience with tamoxifen in peritoneal fibrosing syndromes.Adv Perit Dial2003; 19: 32–5.
